7Baggers
 Soligenix appoints Guarino chief financial officer  NJBIZ Wed, 12 Nov 2025 21:04:47 GMT
 soligenix, inc. reports q3 2025 financial results  The Globe and Mail Sun, 09 Nov 2025 04:54:05 GMT
 Soligenix, Inc. Reports Q3 2025 Financial Results  TipRanks Sat, 08 Nov 2025 04:51:21 GMT
 form 424b3 soligenix, inc.  StreetInsider Fri, 07 Nov 2025 21:12:18 GMT
 Soligenix Bets Big On Clinical Trials Despite No Revenue  Finimize Fri, 07 Nov 2025 20:03:44 GMT
 biopharma firm soligenix's q3 net loss widens on increased r&d spends  MarketScreener Fri, 07 Nov 2025 12:43:12 GMT
 published on: 2025-11-06 06:58:34  Fundação Cultural do Pará Thu, 06 Nov 2025 09:58:34 GMT
 published on: 2025-11-06 06:30:05  Fundação Cultural do Pará Thu, 06 Nov 2025 09:30:05 GMT
 published on: 2025-11-06 06:01:07  Fundação Cultural do Pará Thu, 06 Nov 2025 09:01:07 GMT
 published on: 2025-11-06 04:59:59  Fundação Cultural do Pará Thu, 06 Nov 2025 07:59:59 GMT
 u.s. severe oral mucositis market set for dynamic growth with key  openPR.com Wed, 05 Nov 2025 09:16:19 GMT

Soligenix, Inc
(NASDAQ:SNGX) 

SNGX stock logo

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301, a no...

Founded: 1987
Full Time Employees: 15
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends